Bread Financial Holdings Delinquency Rate Rose in February-February 2024-www.financetom.com

Bread Financial Holdings Delinquency Rate Rose in February

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Bread Financial Holdings Delinquency Rate Rose in February

Mar 13, 2024 8:57 AM

11:35 AM EDT, 03/13/2024 (MT Newswires) -- Bread Financial Holdings ( BFH ) reported a February delinquency rate of 6.7%, up from 6% a year earlier.

The net loss rate in the month ended Feb. 29 was 8.9%, compared with 7.8% a year earlier, the company said Wednesday.

Bread Financial ( BFH ) shares rose 3.2% in recent trading Wednesday.

Price: 37.85, Change: +1.17, Percent Change: +3.19

Previous page： Amgen profit beats estimates, weight-loss data due by year-end Next page： Infleqtion and Churchill Capital Corp X Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Amgen profit beats estimates, weight-loss data due by year-end

Nov 4, 2025

Nov 4 (Reuters) - Amgen ( AMGN ) on Tuesday reported quarterly financial results that beat Wall Street expectations as product sales rose 12%, offsetting higher operating expenses related to experimental weight-loss drug MariTide and a higher tax rate. The California-based biotech company's third-quarter revenue also rose 12% from a year earlier to $9.56 billion. Adjusted earnings per share increased...

Infleqtion and Churchill Capital Corp X Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination

Nov 4, 2025

BOULDER, Colo. & NEW YORK--(BUSINESS WIRE)-- Infleqtion, a global leader in neutral-atom–based quantum technology, and Churchill Capital Corp X ( CCCX ) , a publicly traded special purpose acquisition company, today announced the confidential submission of a draft registration statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) on October 29, 2025. The submission...

Astronics Q3 sales miss estimates

Nov 4, 2025

Overview * Astronics ( ATRO ) Q3 sales up 3.8% to $211.4 mln, missing analyst expectations * Company reports Q3 net loss of $11.1 mln due to refinancing-related charges * Adjusted EBITDA for Q3 was $32.7 mln, or 15.5% of sales Outlook * Company expects Q4 revenue between $225 mln and $235 mln * Astronics ( ATRO ) sees 2025...

Niagen Bioscience Q3 sales beat estimates on strong e-commerce performance

Nov 4, 2025

Overview * Niagen Bioscience ( NAGE ) Q3 net sales rise 33%, beating analyst expectations * Adjusted EBITDA for Q3 increases 120%, reflecting improved operational performance * Company reaffirms full-year net sales growth outlook of 25% to 30% Outlook * Niagen Bioscience ( NAGE ) reaffirms 2025 net sales growth of 25% to 30% y-o-y * Company expects 2025 gross...